Exercise and Parkinson's Disease — What Does the Meta-Analysis Show?

Parkinson's disease is a chronic, progressive neurodegenerative condition rooted in the gradual loss of dopaminergic neurons in the substantia nigra — the brain structure responsible for smooth control of movement. The resulting drop in dopamine leads to characteristic motor symptoms: slowness of movement (bradykinesia), muscle rigidity, resting tremor, and disturbances of balance and posture. The disease most often affects people over 60, though earlier-onset cases also occur.

This is a serious, lifelong diagnosis. Current treatment — primarily dopaminergic pharmacotherapy (levodopa and related drugs), and in selected cases deep brain stimulation — eases symptoms and improves quality of life, but does not stop or reverse the underlying neurodegenerative process. Given this context, it's important to state clearly up front: no form of physical activity cures Parkinson's disease or replaces neurological treatment. This article covers what science says about physical activity as an addition to standard therapy — not as an alternative to it.

Interest in physical activity in Parkinson's disease stems from two independent observations. The first is purely clinical: regular movement improves muscle strength, joint range of motion, coordination, and cardiorespiratory fitness in almost everyone, regardless of underlying disease — and patients with Parkinson's, whose motor function is gradually declining anyway, may benefit from this in a particularly noticeable way.

The second observation is more speculative and remains an area of active research rather than an established fact: animal models and some human studies have suggested that aerobic exercise may favorably influence the plasticity of the brain's motor circuits and neurotrophic factors (such as BDNF), which could theoretically have a neuroprotective effect. We stress the word "theoretically" — this is a mechanistic hypothesis studied mainly in animal models and early human research, not a confirmed, established clinical mechanism. This article relies exclusively on solid clinical data on motor effects, not on speculation about neuroprotection.

It's worth understanding what the standardized mean difference (SMD) actually is — a measure of effect size that is independent of the specific measurement scale used in individual studies, allowing results from tests that measure motor function in different ways to be combined. A value of -0.57, under Cohen's commonly used classification, corresponds to a moderate effect — clearly larger than a small one (about 0.2), but considerably smaller than a large one (0.8 or more). This is an important interpretive caveat: we're talking about a real but limited improvement, not a breakthrough or dramatic effect.

Parkinson's disease is associated with an elevated risk of balance disturbances and falls, particularly in more advanced stages and in the presence of orthostatic hypotension (drops in blood pressure on changing position), which can be a side effect of some dopaminergic drugs. This means the choice of exercise type, intensity, and conditions shouldn't be random or determined solely by the patient based on generic recommendations found online.

In clinical practice, exercise programs for patients with Parkinson's disease are usually led, or at least developed in consultation with, a physiotherapist experienced in working with neurodegenerative diseases, rather than being based solely on general physical activity guidelines for healthy people. The variety of interventions in the studies included in the meta-analysis reflects precisely this fact — the choice of exercise depends on disease stage, baseline function, and the patient's individual limitations.

The data from this meta-analysis are credible in what they actually show: a moderate but real improvement in motor function with regular aerobic physical activity carried out alongside neurological treatment. They are not, however, evidence that exercise replaces medication, slows neurodegeneration, or is risk-free without appropriate supervision. Parkinson's disease is characterized by considerable individual variability, which is why every decision about the type and intensity of exercise should be made together with the treating medical team — not based on general recommendations from an article on the internet, including this one.